Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-18

Clinical Trial Update: Zolmitriptane as Prophylaxis for Chilhood Migraine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating zolmitriptane as prophylaxis for childhood migraine is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptane (zolmitriptane)

Snippet

Sponsor: Tanta University | Conditions: Migraine | Phase 4 | Status: UNKNOWN